Fritextsökning
Innehållstyper
-
Bayer has cut 1,500 roles – so far
German chemical and pharmaceutical group Bayer cut more than 1,500 roles in the first quarter alone– and most of them were management positions.
-
Higher throughput in less time
Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...
-
New features in ZEISS CALYPSO 2024
ZEISS CALYPSO is your universal software for dimensional metrology applications.
-
Join us at SLAS Barcelona
Festo LifeTech is exhibiting at the SLAS in Barcelona.
-
ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin
More than 50 distinguished speakers from leading manufacturing companies.
-
SGS Fimko Ltd.
-
Ready-to-install solutions for the lab-on-a-chip
Design for manufacturing lab-on-a-chip devices Reducing time-to-market together
-
Astra Zeneca's Covid-19 vaccine Vaxzevria is being withdrawn worldwide
AstraZeneca initiates a worldwide withdrawal of its Covid vaccine Vaxzevria. The measure is taken just months after the company admitted the vaccine can cause a...
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
Fuskanklagat pharmabolag lägger ner alzheimerprojekt
Amerikanska Cassava Sciences avbryter utvecklingen av sin läkemedelskandidat inom Alzheimers sjukdom efter misslyckande i en fas III-studie
-
Ancient DNA provides new insights – “The immune system lost its job”
Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...
-
Wusson Accelerator AB
-
Introducing ZEISS arivis Pro 4.2
ZEISS arivis software enhances custom microscopy image analysis.
-
WuXi AppTec, UK Ltd
-
Sobis läkemedel för blödarsjuka får grönt ljus i EU
Det svenska särläkemedelsbolaget Sobi har fått ett positivt omdöme i EU för sin nya behandling mot hemofili A. I ett utlåtande från den europeiska läkemedelsmyn...
-
Come see us at the upcoming events!
We have some upcoming events where you can see our latest products live!
-
Assignment: Facilitate the retention of foreign researchers
A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.
-
Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease
According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...
-
Stopp för subventionerad botox vid skönhetsingrepp
Läkemedel med botulinumtoxin A – den aktiva substansen i botox – ska inte subventioneras längre när de används för estetisk injektionsbehandling.
-
Setback for Moderna in patent dispute with mRNA competitors
Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.
-
JMP Statistical Discovery
-
New Horizons in Biologics & Bioprocessing: Copenhagen 2026
-
TFS Trial Form Support AB
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...